oxaliplatin

Open Access
Comparative Antitumor Efficacy and Toxicity Profile of SCC5, An Ag(I) N-Heterocyclic Carbene Complex, Relative to Platinum-based Chemotherapeutics
JOSEPH A. BAUER, ANNETTE M. SYSEL and MICHAEL J. DUNPHY

Anticancer Research September 2025, 45 (9) 3629-3637; DOI: https://doi.org/10.21873/anticanres.17727
You have access
A Phase II Trial of Pemetrexed Plus Oxaliplatin in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin-based Chemotherapy
JWA HOON KIM, CHANGHOON YOO, HYEHYUN JEONG, JAEKYUNG CHEON, KYU-PYO KIM, BAEK-YEOL RYOO, HEUNG-MOON CHANG, CHUNG RYUL OH, HYE WON RYU and INKEUN PARK

Anticancer Research September 2025, 45 (9) 3983-3991; DOI: https://doi.org/10.21873/anticanres.17756
You have access
Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therapy
YAOYI ZHANG, XIAOHUI LI, SHENG LI, ZHIJIAN YANG, ROBERT M. HOFFMAN and CHEN YU

Anticancer Research January 2025, 45 (1) 399-404; DOI: https://doi.org/10.21873/anticanres.17428
You have access
Pharmacokinetic-toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin-induced Peripheral Neuropathy
YASUHITO TSUKUSHI, SHINJI KOBUCHI, YUKAKO ITO and TOSHIYUKI SAKAEDA

Anticancer Research February 2024, 44 (2) 575-584; DOI: https://doi.org/10.21873/anticanres.16846
Open Access
Long-term Results of a Phase II Study of Neoadjuvant SOX for Advanced Gastric Cancer
SHUNICHI ITO, HIDEKAZU KURAMOCHI, AKIKO SERIZAWA, MASAHO OTA, SATOSHI KATAGIRI, SHINSUKE MAEDA and KEI HOSODA

Anticancer Research January 2024, 44 (1) 195-204; DOI: https://doi.org/10.21873/anticanres.16802
You have access
PARP Inhibitor Sensitizes BRCA-mutant Pancreatic Cancer to Oxaliplatin by Suppressing the CDK1/BRCA1 Axis
CHORONG KIM, DANBEE KIM, DA SOL LEE, SEONMIN LEE, CHANGHOON YOO and KYU-PYO KIM

Anticancer Research December 2023, 43 (12) 5523-5534; DOI: https://doi.org/10.21873/anticanres.16754
Open Access
Proton Pump Inhibitors Ameliorate Oxaliplatin-induced Peripheral Neuropathy: Retrospective Analysis of Two Real-world Clinical Databases
AKIHIDE KOBAYASHI, KENJI IKEMURA, ERI WAKAI, MASAYOSHI KONDO and MASAHIRO OKUDA

Anticancer Research December 2023, 43 (12) 5613-5620; DOI: https://doi.org/10.21873/anticanres.16764
You have access
Adjuvant Chemotherapy With S-1 Plus Docetaxel Versus S-1 Plus Oxaliplatin in Stage III Gastric Cancer
MASAAKI YAMAMOTO, TAKESHI OMORI, NAOKI SHINNO, HISASHI HARA, YOSUKE MUKAI, TAKAHITO SUGASE, TOMOHIRA TAKEOKA, MANABU MIKAMORI, TAKASHI KANEMURA, SHINICHIRO HASEGAWA, HIROFUMI AKITA, NAOTSUGU HARAGUCHI, JUNICHI NISHIMURA, HIROSHI WADA, CHU MATSUDA, MASAYOSHI YASUI, HIROSHI MIYATA and MASAYUKI OHUE

Anticancer Research November 2023, 43 (11) 5015-5024; DOI: https://doi.org/10.21873/anticanres.16700
You have access
Efficacy and Safety of Oxaliplatin-based Regimens as First-line Chemotherapy in Elderly Patients With Metastatic Colorectal Cancer
SEIJI YAMAMOTO, HIRONORI FUJII, KOTARO MURAYAMA, HIROTOSHI IIHARA, DAICHI WATANABE, YUNAMI YAMADA, RYO KOBAYASHI, SHIGERU KIYAMA, AKITAKA MAKIYAMA, KIMIHIKO URANO, NOBUHISA MATSUHASHI, AKIO SUZUKI and KATSUHIKO MATSUURA

Anticancer Research November 2023, 43 (11) 5099-5105; DOI: https://doi.org/10.21873/anticanres.16710
You have access
Vitamin C Improves the Inhibitory Effects of Oxaliplatin on HCT-116 Colorectal Cancer Growth and Progression Through Cellular Oxidant Function-associated Cadherin Molecules
PORNNAPAT CHUSANGNIN, THARATHIP MUANGTHONG, WITCHUDA PAYUHAKRIT, SARAWOOT PALIPOCH and PRASIT SUWANNALERT

Anticancer Research October 2023, 43 (10) 4461-4472; DOI: https://doi.org/10.21873/anticanres.16641

Main menu

User menu

Search

oxaliplatin

Pages